Welcome Guest
Sign In
Register
Products
Popular Categories
Antibody Search
ELISA Kit Search
Biomolecules
Flow Cytometers
Thermal Cyclers
Microscopes
Transfection Reagents
Featured Products
New Products
Articles
Resources
eBooks
Bench Tips
Tech Insights
Editorial Articles
News
Product Reviews
Future Lab
Multimedia
Biocompare Webinars
Immunotherapy
Reproducibility
Transformative Technologies
Podcasts
Tech Talks
Bench Tip Videos
All Videos and Webinars
Life Science Webinars
Write a Review
Antibodies
Kits/Reagents
Equipment
Services
Resources
Promotions
Events
AACR SPOTLIGHT
Register
Sign In
Biocompare
Products
Antibodies
Antibodies
Mouse Anti-VIM.L Recombinant Antibody (14h7)
Mouse Anti-VIM.L Recombinant Antibody (14h7) from Creative Biolabs
Be the first to write a review!
Supplier Page
Supplier Page from
Creative Biolabs for
Mouse Anti-VIM.L Recombinant Antibody (14h7)
The
Mouse Anti-VIM.L Recombinant Antibody (14h7)
from
Creative Biolabs
is a Mouse Monoclonal antibody. This antibody recognizes Xenopus/Amphibian antigen.
Product Specs
Company Info
Reviews
Product Specs
Item
Mouse Anti-VIM.L Recombinant Antibody (14h7)
Company
Creative Biolabs
Price
Supplier Page
View Company Product Page
Catalog Number
CBMAB-0032-CN
Format
Liquid
Reactivity
Xenopus
Target
VIM.L
Isotype
IgG1
Clone
14h7
Host
Mouse
Clonality
Monoclonal
Immunogen
Cell insoluble residues derived from the Xenopus kidney epithelial cell line A6 (mainly containing intermediate filaments)
Purity
>95%, as determined by SDS-PAGE analysis
NCBI Full Gene Name
vimentin L homeolog
NCBI Gene Aliases
vim, vim-a, vim-b, vim1, vim2
Add to Compare List
Creative Biolabs
SUITE 203, 17 Ramsey Road
Shirley
,
NY
11967
United States
Phone
: 1-631-357-2254
1-631-416-1478
Email: info@creative-biolabs.com
Company Profile
Website:
https://www.creativebiolabs.net/
Website:
https://www.creativebiolabs.net/
Reviews
Be the First to Write a Review!
Mouse Anti-VIM.L Recombinant Antibody (14h7) from Creative Biolabs
Supplier Page
View Company Product Page
Product Specs
Company Info
Reviews
Back To Top